Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Intermediate Risk Prostate Cancer (Diagnosis)”

277 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 277 results

Early research (Phase 1)Study completedNCT00987376
What this trial is testing

Novel PET/CT Agents and MRS/MRI in Prostate CA and High Risk Prostate Cancer: An Inter-SPORE Collaboration

Who this might be right for
Prostate Cancer
Mayo Clinic 8
Testing effectiveness (Phase 2)UnknownNCT00657982
What this trial is testing

Phase II Study of RAD001 in a Neoadjuvant Setting in Men With Intermediate or High Risk Prostate Cancer

Who this might be right for
Prostate Cancer
Sheba Medical Center 15
Not applicableApproved For MarketingNCT04452136
What this trial is testing

Expanded Access Protocol of 68Ga PSMA 11 PET Imaging of Prostate Cancer

Who this might be right for
Prostatic NeoplasmsProstatic DiseasesProstate Cancer+2 more
Jeanne Link
Testing effectiveness (Phase 2)Study completedNCT00006359
What this trial is testing

Androgen Suppression Plus Radiation Therapy in Treating Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
Alliance for Clinical Trials in Oncology 63
Not applicableUnknownNCT01972867
What this trial is testing

Study of NanoKnife for Ablation of Prostate Cancer in Intermediate Risk Patients

Who this might be right for
Prostate Cancer
Angiodynamics, Inc. 6
Not applicableActive Not RecruitingNCT03998657
What this trial is testing

Continued Access of Focal MR-Guided Focused Ultrasound for Localized Intermediate Risk Prostate Lesions

Who this might be right for
Prostate Cancer
InSightec 14
Not applicableLooking for participantsNCT03650595
What this trial is testing

MRI Guided Focal Laser Ablation of Prostate Cancer

Who this might be right for
Prostate CancerLow and Intermediate Risk Prostate Cancer
University Health Network, Toronto 102
Not applicableLooking for participantsNCT07219303
What this trial is testing

Adaptive Radiation Therapy for Men With Intermediate- or High-Risk Prostate Cancer

Who this might be right for
Prostate Cancer (Adenocarcinoma)
Fox Chase Cancer Center 80
Testing effectiveness (Phase 2)Active Not RecruitingNCT05003752
What this trial is testing

Hypo-Combi Trial: Hypofractionated EBRT Plus HDR-BT Boost for Prostate Cancer

Who this might be right for
Prostate AdenocarcinomaRadiation Toxicity
German Oncology Center, Cyprus 40
Testing effectiveness (Phase 2)Looking for participantsNCT05557604
What this trial is testing

Sbrt±sTad for Unfavorable iNtermediate rIsk/High Risk Prostate caNcer

Who this might be right for
Prostate Cancer
Regina Elena Cancer Institute 146
Early research (Phase 1)Study completedNCT02390063
What this trial is testing

Vaccination in Prostate Cancer (VANCE)

Who this might be right for
Prostate Cancer
University of Oxford 40
Not applicableEnded earlyNCT01045226
What this trial is testing

Proton Radiation Therapy in Treating Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
Abramson Cancer Center at Penn Medicine 300
Testing effectiveness (Phase 2)Study completedNCT03373006
What this trial is testing

A Phase II Study to Evaluate Axumin PET/CT for Risk Stratification for Prostate Cancer

Who this might be right for
Prostate Cancer
HALO Diagnostics 20
Not applicableUnknownNCT00407875
What this trial is testing

Intensity Modulated Versus Interstitial - Radiation Therapy

Who this might be right for
Prostate Cancer
British Columbia Cancer Agency 50
Not applicableActive Not RecruitingNCT05361902
What this trial is testing

A First Step Towards Ultra-hypofractionation for Unfavourable Intermediate and High-risk Prostate Cancer

Who this might be right for
Prostate Cancer
Erasmus Medical Center 35
Not applicableStudy completedNCT01664130
What this trial is testing

High-Dose Stereotactic Radiation for Prostate Cancer

Who this might be right for
Adenocarcinoma of the ProstateRecurrent Prostate CancerStage I Prostate Cancer+3 more
Case Comprehensive Cancer Center 35
Testing effectiveness (Phase 2)Looking for participantsNCT06111781
What this trial is testing

The SUGAR Study; SBRT and Relugolix) for Prostate Cancer

Who this might be right for
Prostate Cancer
Yale University 60
Testing effectiveness (Phase 2)UnknownNCT03080116
What this trial is testing

Neoadjuvant Degarelix With or Without Apalutamide (ARN-509) Followed by Radical Prostatectomy

Who this might be right for
Prostate CancerNeoadjuvant TherapyAndrogen Antagonists+1 more
Universitaire Ziekenhuizen KU Leuven 90
Testing effectiveness (Phase 2)Active Not RecruitingNCT03444844
What this trial is testing

Biodistribution and Dosimetry of Ga-68 P16-093 in Prostate Cancer

Who this might be right for
Prostate Cancer RecurrentProstate Cancer
Five Eleven Pharma, Inc. 60
Large-scale testing (Phase 3)Study completedNCT00667069
What this trial is testing

Triptorelin and Radiation Therapy in Treating Patients Who Have Undergone Surgery for Intermediate-Risk Stage III or Stage IV Prostate Cancer

Who this might be right for
Prostate Cancer
UNICANCER 424
Next Page